ABBV-4083
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABBV-4083, covering 2024-09-19 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-4083 Capsules When Given Alone or In Combination With Albendazole Capsules Moves in The Body of Adult Participants With Onchocerca Volvulus Infection [Phase 2]